Effects of Rosiglitazone on Plasma BNP Levels and Left Ventricular Dysfunction

Clinical trial NCT00300911 · COMPLETED

Trial details

NCT number: NCT00300911
Sponsor: Baskent University
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 2

Start date: 2005-12-01
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.